We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXFR icon
2501
Luxfer Holdings
LXFR
$456M
$327K ﹤0.01%
+23,865
New +$348K
BRLT icon
2502
Brilliant Earth
BRLT
$17.9M
$326K ﹤0.01%
75,703
-31,144
-29% -$186K
BRMK
2503
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$326K ﹤0.01%
+91,579
New +$426K
FFTY icon
2504
CapForce IBD 50 ETF
FFTY
$78.8M
$324K ﹤0.01%
14,871
+800
+6% +$19.7K
RMBS icon
2505
Rambus
RMBS
$8.98B
$324K ﹤0.01%
+9,049
New +$306K
AVXL icon
2506
Anavex Life Sciences
AVXL
$231M
$324K ﹤0.01%
+34,996
New +$374K
KRON
2507
DELISTED
Kronos Bio
KRON
$323K ﹤0.01%
199,608
-41,291
-17% -$95K
ACWV icon
2508
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.34B
$323K ﹤0.01%
+3,400
New +$319K
RGP icon
2509
Resources Connection
RGP
$140M
$322K ﹤0.01%
+17,546
New +$322K
CFR icon
2510
Cullen/Frost Bankers
CFR
$10.5B
$322K ﹤0.01%
+2,409
New +$342K
ABST
2511
DELISTED
Absolute Software Corp
ABST
$321K ﹤0.01%
+30,792
New +$321K
STAA icon
2512
STAAR Surgical
STAA
$1.19B
$320K ﹤0.01%
+6,600
New +$414K
VRA icon
2513
Vera Bradley
VRA
$98.7M
$320K ﹤0.01%
70,603
-28,998
-29% -$106K
HEWJ icon
2514
iShares Currency Hedged MSCI Japan ETF
HEWJ
$713M
$318K ﹤0.01%
+12,140
New +$428K
GEN icon
2515
Gen Digital
GEN
$16.5B
$317K ﹤0.01%
14,787
-2,243,965
-99% -$49.6M
BCAB icon
2516
BioAtla
BCAB
$5.34M
$317K ﹤0.01%
+768
New +$319K
IGF icon
2517
iShares Global Infrastructure ETF
IGF
$10.9B
$316K ﹤0.01%
6,900
-1,527
-18% -$68.7K
TEX icon
2518
Terex
TEX
$7.37B
$316K ﹤0.01%
7,402
-5,098
-41% -$205K
PRPC.WS
2519
CALL
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$316K ﹤0.01%
31,243
VFH icon
2520
Vanguard Financials ETF
VFH
$13.4B
$314K ﹤0.01%
3,800
-5,564
-59% -$460K
EPSN icon
2521
Epsilon Energy
EPSN
$168M
$314K ﹤0.01%
47,371
-5,611
-11% -$38.7K
KOS icon
2522
Kosmos Energy
KOS
$1.47B
$314K ﹤0.01%
49,342
-9,158
-16% -$57.2K
TSE
2523
DELISTED
Trinseo
TSE
$313K ﹤0.01%
13,799
-317,511
-96% -$7M
HDSN
2524
Hudson Technologies
HDSN
$246M
$313K ﹤0.01%
+30,953
New +$302K
EWBC icon
2525
East-West Bancorp
EWBC
$17.8B
$311K ﹤0.01%
+4,723
New +$323K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.